Your browser doesn't support javascript.
loading
Randomized Phase II Study of Two Doses of Pixantrone in Patients with Metastatic Breast Cancer (NCCTG N1031, Alliance).
Sideras, Kostandinos; Hillman, David W; Giridhar, Karthik; Ginos, Brenda F; Tenglin, Richard C; Liu, Heshan; Chen, Beiyun; Tan, Winston; Gross, Gerald G; Mowat, Rex B; Dueck, Amylou C; Perez, Edith A; Moreno-Aspitia, Alvaro.
Affiliation
  • Sideras K; Mayo Clinic, Jacksonville, FL, USA.
  • Hillman DW; Mayo Clinic, Rochester, MN, USA.
  • Giridhar K; Mayo Clinic, Rochester, MN, USA.
  • Ginos BF; Mayo Clinic, Rochester, MN, USA.
  • Tenglin RC; Rapid City Regional Hospital, Rapid City, SD, USA.
  • Liu H; Mayo Clinic, Rochester, MN, USA.
  • Chen B; Mayo Clinic, Rochester, MN, USA.
  • Tan W; Mayo Clinic, Jacksonville, FL, USA.
  • Gross GG; Roger Maris Cancer Center, Fargo, ND, USA.
  • Mowat RB; Toledo Community Hospital Oncology Program, Toledo, OH, USA.
  • Dueck AC; Mayo Clinic, Rochester, MN, USA.
  • Perez EA; Mayo Clinic, Jacksonville, FL, USA.
  • Moreno-Aspitia A; Mayo Clinic, Jacksonville, FL, USA.
Oncologist ; 2022 Apr 21.
Article in En | MEDLINE | ID: mdl-35445723

Full text: 1 Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2022 Type: Article Affiliation country: United States